We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Cancer Invasion Identified with Surgical Fluorescence Technique

By HospiMedica International staff writers
Posted on 22 Jan 2013
A new study describes a technique that will allow intraoperative detection of lymph node cancer metastases, so that healthy tissue can be preserved.

Researchers at the University of California, San Diego (UCSD; USA) have developed injectable fluorescently labeled molecules, which have been termed ratiometric activatable cell-penetrating peptides (RACPP). More...
When used in mouse models, the peptides allowed surgeons to see where the cancer had spread with high sensitivity and specificity, even when the metastatic sites were only a few millimeters in size. The new technique could decrease time under anesthesia, since the surgical team need not wait for pathology reports, as well reducing unnecessary surgery on noncancerous lymph nodes.

This form of “instant pathology” is an important improvement over traditional sentinel node mapping, whereby only the location of the lymph node is detected, without gleaning any information on actual cancer involvement. Additionally, current methods for managing prostate cancer and neck squamous cell carcinoma, for example, only reveal the extent of cancer involvement after the patient has undergone surgical removal of all susceptible lymph nodes. The study was published in the January 15, 2012, issue of Cancer Research.

“With molecular-targeted imaging, surgeons can avoid unnecessary removal of healthy lymph nodes which is better long-term for patients,” said lead author associate Professor Quyen T. Nguyen, MD, PhD, director of the facial nerve clinic at UCSD Health System. “The range of the surgeon's visual field is greatly enhanced by a molecular tool that can help achieve accurate surgical margins and detection of metastases so that no tumor is left behind.”

Lymph nodes, located throughout the body, serve as biologic filters that contain immune cells to fight infection and clean the blood. When cancer cells break away from a tumor, the cells can travel through the lymph system; sentinel node surgery allows the surgeon to remove the nodes to determine cancer spread. Human nodes, however, are only half a centimeter in size, and are difficult to discern among the surrounding tissue during surgery. Furthermore, even when surgeons are able to map the location of the nodes, there is no current technique that indicates whether the lymph nodes contain cancer, requiring removal of more lymph nodes than necessary.

Related Links:
University of California, San Diego


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.